Literature DB >> 19675298

Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart.

J Andrew Wasserstrom1, Rohan Sharma, Matthew J O'Toole, Jiabo Zheng, James E Kelly, John Shryock, Luiz Belardinelli, Gary L Aistrup.   

Abstract

Pathological conditions, including ischemia and heart failure, are associated with altered sodium channel function and increased late sodium current (I(Na,L)), leading to prolonged action potential duration, increased intracellular sodium and calcium concentrations, and arrhythmias. We used anemone toxin (ATX)-II to study the effects of increasing I(Na,L) on intracellular calcium cycling in rat isolated hearts. Cardiac contraction was abolished using paralytic agents. Ranolazine (RAN) was used to inhibit late I(Na). Hearts were loaded with fluo-4-acetoxymethyl ester, and myocyte intracellular calcium transients (CaTs) were measured using laser scanning confocal microscopy. ATX (1 nM) prolonged CaT duration at 50% recovery in hearts paced at a basal rate of 2 Hz and increased the sensitivity of the heart to the development of calcium alternans caused by fast pacing. ATX increased the time required for recovery of CaT amplitude following a previous beat, and ATX induced spontaneous calcium release waves during rapid pacing of the heart. ATX prolonged the duration of repolarization from the initiation of the activation to terminal repolarization in the pseudo-electrocardiogram. All actions of ATX were both reversed and prevented by subsequent or prior exposure, respectively, of hearts to RAN (10 microM). Most importantly, the increased vulnerability of the heart to the development of calcium alternans during rapid pacing was reversed or prevented by 10 microM RAN. These results suggest that enhancement of I(Na,L) alters calcium cycling. Reduction by RAN of I(Na,L)-induced dysregulation of calcium cycling could contribute to the antiarrhythmic actions of this agent in both reentrant and triggered arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675298     DOI: 10.1124/jpet.109.156471

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations.

Authors:  Balazs Horvath; Tamas Banyasz; Zhong Jian; Bence Hegyi; Kornel Kistamas; Peter P Nanasi; Leighton T Izu; Ye Chen-Izu
Journal:  J Mol Cell Cardiol       Date:  2013-09-06       Impact factor: 5.000

2.  Calcium-voltage coupling in the genesis of early and delayed afterdepolarizations in cardiac myocytes.

Authors:  Zhen Song; Christopher Y Ko; Michael Nivala; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

3.  Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2.

Authors:  Ashish Parikh; Rajkumar Mantravadi; Dmitry Kozhevnikov; Michael A Roche; Yanping Ye; Laura J Owen; Jose Luis Puglisi; Jonathan J Abramson; Guy Salama
Journal:  Heart Rhythm       Date:  2012-01-11       Impact factor: 6.343

Review 4.  Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence.

Authors:  Zhilin Qu; James N Weiss
Journal:  Annu Rev Physiol       Date:  2014-10-17       Impact factor: 19.318

5.  Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine.

Authors:  Norishige Morita; Jong Hwan Lee; Yuanfang Xie; Ali Sovari; Zhilin Qu; James N Weiss; Hrayr S Karagueuzian
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

6.  T-tubule disruption promotes calcium alternans in failing ventricular myocytes: mechanistic insights from computational modeling.

Authors:  Michael Nivala; Zhen Song; James N Weiss; Zhilin Qu
Journal:  J Mol Cell Cardiol       Date:  2014-11-06       Impact factor: 5.000

Review 7.  Pathophysiology of the cardiac late Na current and its potential as a drug target.

Authors:  Jonathan D Moreno; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2011-12-16       Impact factor: 5.000

Review 8.  Electrophysiologic basis for the antiarrhythmic actions of ranolazine.

Authors:  Charles Antzelevitch; Alexander Burashnikov; Serge Sicouri; Luiz Belardinelli
Journal:  Heart Rhythm       Date:  2011-03-21       Impact factor: 6.343

Review 9.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

10.  Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.

Authors:  Jonathan D Moreno; Pei-Chi Yang; John R Bankston; Eleonora Grandi; Donald M Bers; Robert S Kass; Colleen E Clancy
Journal:  Circ Res       Date:  2013-07-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.